88IV - PR Newswire Asia's news


WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Technology Platform to Ona Therapeutics to Advance Novel ADC Research and Development SHANGHAI , Sept. 17, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing ... 2026-09-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs 22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advances ... 2026-09-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
111, Inc. Announces Second Quarter 2026 Unaudited Financial Results Transition from An Asset-Heavy Business Model to An Asset-Light Business Model Ongoing Investment and Adoption of AI Agents Making Workforce Streamlining Possible Net Revenue of Promotional Products ... 2026-09-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Multimedia/Online/Internet
Akeso's EGFR/TROP2 Bispecific ADC AK158D1 Granted NMPA Phase I Clearance for Advanced Solid Tumors, Marking Its Fourth Clinical-Stage ADC Candidate HONG KONG , Sept. 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that AK158D1, its investigational next-generation bispecific antibody-drug conjugate ... 2026-09-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody Cesalatamig is Currently Being Evaluated in Phase 1/2 Studies in the United States ( NCT06635785 ) and in China ( CTR20253261 ) Fast Track Designation Supports Expedited Development of Cesalatamig ... 2026-09-16T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nona Biosciences Successfully Develops World's First Language Model Trained on Fully Human Heavy-Chain-Only Antibodies CAMBRIDGE, Mass. , Sept. 16, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology ... 2026-09-16T Biotechnology
WuXi Biologics Named to Forbes China ESG 50 List 2026 for Green CRDMO and Digital ESG Leadership SHANGHAI , Sept. 16, 2026 /PRNewswire/ -- Forbes China recently released the 2026 Forbes China ESG 50 list. WuXi Biologics was named to the list for its outstanding performance in sustainable development, ... 2026-09-16T Biotechnology Environmental Products & Services Green Technology Health Care/Hospital
GHIT Fund Launches "NTDpedia" to Help Turn Apathy Into Action Against Neglected Tropical Diseases The interactive educational website makes NTDs understandable to a general audience, the first step toward public support that drives R&D for the 1.5 billion people affected by these disease ... 2026-09-16T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Ferronova announces preliminary results of MAGMAP, a 62-patient gastric and oesophageal cancer trial investigating lymph node mapping KYOTO, Japan , Sept. 16, 2026 /PRNewswire/ -- Australian medical technology company Ferronova has announced preliminary findings from the MAGMAP multi-centre trial involving 62 gastric and oesophageal ... 2026-09-16T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease Patients The fifteen-month dataset represents the final analysis from the Phase 1/2 study At the Month 15 primary timepoint, SKY-0515-treated patients showed a +1.59-point difference in Composite Unified Huntington's ... 2026-09-16T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology